Social deprivation stress induces adaptative changes of opioid mechanisms in the rat tail artery

Life Sciences

Volumn 60, Issue 25, 1997, Pages 2315-2322

  Parra, Lucía ^a   Alsasua, Angela ^b   Fuentes, José A ^c   Alguacil, Luis F ^d  

^a Department of Pharmacology ^*

^b School of Medicine

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Opioid tolerance; Social deprivation stress; Tail artery; Vascular reactivity

Indexed keywords

BETA ENDORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; OPIATE RECEPTOR;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; HYPERTENSION; IN VITRO STUDY; MALE; NONHUMAN; RAT; SOCIAL ISOLATION; TAIL ARTERY;

EID: 0030962991     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00287-7     Document Type: Article

References (29)

1. I. JIMÉNEZ, T. IGLESIAS AND J.A. FUENTES, Eur. J. Pharmacol. 182 155-166 (1990).
2. A. FLORENTINO, I. JIMÉNEZ, .R. NARANJO, C. URDÍN AND J.A. FUENTES, Life Sci. 41 2445-2453 (1987).
3. G.R. VAN LOON, PIERZCHALA K., BROWN L.V. and F.A. BOBBITT, Synaptic Transmission Receptors. S. Tucek (Ed.), 355-364, Wiley, Chichester (1987).
4. G.W. TERMAN, E.R. PENNER AND J.C. LIEBESKIND, Brain Res. 360 374-378 (1985).
5. J.W. HOLADAY, . Rev. Pharmacol. Toxicol. 22. 541-594 (1983).
6. G. FEUERSTEIN AND A. SIREN, Circulation 75 (Suppl. I) 1125-1129 (1987).
7. J.R. NARANJO AND J.A. FUENTES, europharmacology 24 167-171 (1985).
8. S.J. PATERSON, L.E. ROBSON AND H.W. KOSTERLITZ, Br. Med. Bull 39 31-36 (1983).
9. H. ENSINGER, L. HEDLER, C. SCHURR and K. STRAKE, aunyn-Schmiedeberg's Arch. Pharmacol. 328 20-23 (1984).
10. H. ENSINGER, L. HEDLER, C. SCHURR and K. STRAKE, . Cardiovasc. Pharmacol. 8 470-475 (1986).
11. P. ILLES, N. PFEIFFER, I. VON KÜGELGEN and K.J. STARKE, . Pharmacol. Exp. Ther. 232 526-533 (1985).
12. N. JOHNSON, R.A. HOUGHTON and G.W. PASTERNAK, Life Sci. 31. 1381-1384 (1982).
13. H.I. MOSBERG, R. HURST, V.J. HRUBY, K. GEE, H.I. YAMAMURA, .J. GALLICAN and T.F. BURKS, . Natl. Acad. Sci. USA 80 5871-5874 (1983).
14. A.D. CORBETT, M.G.C. GILLAN, H.W. KOSTERLITZ, A.T. MCKNIGHT, S.J. PATERSON and L.E. ROBSON, Br. J. Pharmacol. 83 271-279 (1984).
15. P. ILLES, R. BETTER, I. BROD and B. BUCHER, aunyn-Schmiedeberg's Arch. Pharmacol. 335 420-427 (1987).
16. T. IGLESIAS, S. MONTERO, M.J. OTERO, L. PARRA and J.A. FUENTES, Cell. Mol. Neurobiol. 12 547-555 (1992).
17. L. PARRA, F. PÉREZ-VIZCAINO, A. ALSASUA, M. MARTÍN and J. TAMARGO, Eur. J. Pharmacol. 277 99-105 (1995).
18. G.J. TABORSKY, .B. HALTER and D. PORTER, Am. J. Physiol. 242 317-322 (1982).
19. E. WEI and H. LOH, Science 193 1262-1263 (1976).
20. I. JIMÉNEZ and J.A. FUENTES, Pharmacol. Commun. 4 207-213 (1994).
21. W. KROMER and H. TESCHEMACHER, Eur. J. Pharmacol. 42 445-446 (1978).
22. I.J. BODYCOTE and G.B. CHESTER, Eur. J. Pharmacol. 57 259-261 (1979).
23. M.M. PUIG, P. GASCON and J.M. MUSACCHIO, . Pharmacol. Exp. Ther. 206 289-301 (1978).
24. A. REZVANI, J.P. HUIDROBO-TORO, J. HU and E.L. WAY, . Pharmacol. Exp. Ther. 225 251-255 (1983).
25. L.F. ALGUACIL , C. ALAMO, C. SANTOS and E. CUENCA, Life Sci. 40 155-160 (1987).
26. H.O.J. COLLIER, Drug Alcohol Depend. 11 15-21 (1983).
27. A.L. BECKMAN, R.R. DEAN and J.K. WAMSLEY, Brain Res. 386 223-231 (1986).
28. L. PARRA, J.A. FUENTES, and A. ALSASUA, Life Sci. 55 669-675 (1994).
29. H.I. KORNBLUM, D.E. HURLBUT and F.M. LESLIE, Dev. Brain Res. 37 21-41 (1987).